Paravertebral Block for Postoperative Analgesia in Thoracoscopic Surgery
Patient Controlled Paravertebral Analgesia for Video-assisted Thoracoscopic Surgery
1 other identifier
interventional
30
1 country
1
Brief Summary
To access the analgesic efficacy of patient controlled thoracic paravertebral analgesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
July 25, 2017
CompletedFirst Posted
Study publicly available on registry
August 8, 2017
CompletedAugust 8, 2017
August 1, 2017
1 year
July 25, 2017
August 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VAS score at rest and on coughing
Using VAS scale (Atrazennica)
72 hours
Secondary Outcomes (5)
Analgesia effects on respiratory function
three postoperative consecutive days
Arterial blood gas values
three postoperative consecutive days
The number dermatome inhibition
three postoperative consecutive days
Rescue analgesia
three postoperative consecutive days
Patient's satisfaction
three postoperative consecutive days
Other Outcomes (3)
Side effects and complications
three postoperative consecutive days
Heart rate
three postoperative consecutive days
Blood pressure
three postoperative consecutive days
Study Arms (1)
PVB using PVC for PCA in VATS
EXPERIMENTALThe VATS was performed.Paravertebral space was identified by loss of resistance technique combined with video-assisted inside thoracic space before chest close.PVC was inserted.Initiated dose of 0.3ml/kg of Bupivacaine Hydrochloride 1.25mg/ml and Fentanyl Citrate 2 micrograms/ml was administered then continued PCA with background rate 3ml/h, bolus dose 2ml was infused through PVC.
Interventions
General anesthesia was induced with 2.0 mg/kg of propofol, 2.0 mg/kg of fentanyl, and 1.0 mg kg/1 of rocuronium and maintained with continuous infusion 6-12mg/kg/h of propofol,injected 2.0 mg/kg of fentanyl and 0.15 mg/ kg of rocuronium every 30 minutes . All patients were intubated with a double-lumen endobronchial tube for one-lung ventilation.The VATS (Video-Assisted Thoracic Surgery) was performed.
At the end of the surgery, the upper edge of the spinous process of the thoracic vertebral body was recognized. With an epidural needle (Tuohy 22 G; Braun, Melsungen, Germany), the injection point was punctured 2 cm lateral to the midline. The paravertebral space was entered by advancing the Tuohy needle over the superior border of the transverse process. Once in the right place, the PVC was placed through the needle, checking the tip remained placed when removing the needle. The advance of the needle and the entering of the catheter into the paravertebral space were verified all the time by the surgeon using the camera. The PVC (Paravertebral Catheter ) was inserted at this point preversed at this area.
PVC was inserted.Initiated dose of 0.3ml/kg of Bupivacaine Hydrochloride 1.25mg/ml and Fentanyl Citrate 2 micrograms/ml was administered then continued PCA (Perfusor space pump,Germany)with background rate 3ml/h, bolus dose 2ml was infused through PVC.
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists class I to III risk undergoing elective VATS, aged 32-72 years, scheduled for lung resection surgery.
You may not qualify if:
- Patients who refused to participate, less than 18 years of age, ASA physical status 3 or more,, allergy to any of the study drugs, patients having any contraindication to placement of PVB, kyphoscoliosis, presence of acute herpes zoster, chronic pain syndrome, chronic analgesic use and psychiatric disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nguyen Trung Kienlead
- Nguyen Truong Giang, PhD. Associate Prof.collaborator
Study Sites (1)
Vietnam Military Medical University
Hanoi, Vietnam
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Corresponding author,Clinical Research
Study Record Dates
First Submitted
July 25, 2017
First Posted
August 8, 2017
Study Start
June 1, 2016
Primary Completion
June 1, 2017
Study Completion
July 1, 2017
Last Updated
August 8, 2017
Record last verified: 2017-08